| 摘要 |
PROBLEM TO BE SOLVED: To provide therapeutic compositions capable of improving the enhanced efficacy of a peptide active therapeutic agent to be achieved, in relation to the peptide active therapeutic agent alone.SOLUTION: Therapeutic compositions contain fusion proteins (FPs) including elastin-like peptides (ELPs) and peptide active therapeutic agents. Enhanced efficacy of the peptide active therapeutic agent in the therapeutic composition may include improved solubility, bioavailability, bio-unavailability, half-life, etc., as compared to corresponding compositions containing the same peptide active therapeutic agent without associated ELPs. |
